Offer - Urjas Oil for just ₹ 1 X
Nopark 2.5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease.
The optimal dosage of Nopark 2.5 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Nopark 2.5 Mg Tablet as well, which are listed below. Normally, these side effects of Nopark 2.5 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Nopark 2.5 Mg Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Nopark 2.5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nopark 2.5 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Tardive Dyskinesia, Glaucoma are examples of such conditions. Other conditions have been mentioned below in the Nopark 2.5 Mg Tablet contraindications section.
Besides this, Nopark 2.5 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Nopark 2.5 Mg Tablet is not safe while driving, and is not addiction.
Nopark 2.5 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nopark 2.5 Mg Tablet safe for pregnant women?
Nopark can have harmful effects in pregnant women. If you experience any discomfort after using Nopark, then discontinue the use and take your doctor's advice.
Is the use of Nopark 2.5 Mg Tablet safe during breastfeeding?
Nopark should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nopark 2.5 Mg Tablet on the Kidneys?
Very few cases of side effects of Nopark on kidney have been reported.
What is the effect of Nopark 2.5 Mg Tablet on the Liver?
Nopark can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nopark 2.5 Mg Tablet on the Heart?
Nopark may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nopark 2.5 Mg Tablet unless your doctor advises you to do so -
Is this Nopark 2.5 Mg Tablet habit forming or addictive?
No, you will not get addicted to Nopark 2.5 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Nopark 2.5 Mg Tablet. So it is best to avoid driving.
Is it safe?
Nopark 2.5 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Nopark 2.5 Mg Tablet is useful in treating mental disorders.
Interaction between Food and Nopark 2.5 Mg Tablet
Taking Nopark 2.5 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Nopark 2.5 Mg Tablet
Consult your doctor before consuming alcohol while taking Nopark 2.5 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kemadrin (procyclidine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433